Retirement Funds Sue Valeant for Billions Lost Through Price-Gouging Scheme

Drug Industry Daily
A A
A group of investors sued Valeant Pharmaceuticals claiming the drugmaker cost them more than $80 billion through price-gouging.

To View This Article:

Login

Subscribe To Drug Industry Daily